- Home
- CPIX vs CNTB Comparison
CPIX vs CNTB Comparison
Compare CPIX & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- CNTB
- Stock Information
- Founded
- CPIX 1999
- CNTB 2012
- Country
- CPIX United States
- CNTB United States
- Employees
- CPIX N/A
- CNTB N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- CPIX Health Care
- CNTB Health Care
- Exchange
- CPIX Nasdaq
- CNTB Nasdaq
- Market Cap
- CPIX 68.7M
- CNTB 55.2M
- IPO Year
- CPIX 2009
- CNTB 2021
- Fundamental
- Price
- CPIX $4.76
- CNTB $0.74
- Analyst Decision
- CPIX
- CNTB Strong Buy
- Analyst Count
- CPIX 0
- CNTB 1
- Target Price
- CPIX N/A
- CNTB $8.00
- AVG Volume (30 Days)
- CPIX 43.3K
- CNTB 258.1K
- Earning Date
- CPIX 05-06-2025
- CNTB 03-31-2025
- Dividend Yield
- CPIX N/A
- CNTB N/A
- EPS Growth
- CPIX N/A
- CNTB N/A
- EPS
- CPIX N/A
- CNTB N/A
- Revenue
- CPIX $37,867,945.00
- CNTB $26,033,000.00
- Revenue This Year
- CPIX N/A
- CNTB N/A
- Revenue Next Year
- CPIX N/A
- CNTB N/A
- P/E Ratio
- CPIX N/A
- CNTB N/A
- Revenue Growth
- CPIX N/A
- CNTB N/A
- 52 Week Low
- CPIX $1.04
- CNTB $0.51
- 52 Week High
- CPIX $7.25
- CNTB $2.08
- Technical
- Relative Strength Index (RSI)
- CPIX 56.04
- CNTB 50.81
- Support Level
- CPIX $3.98
- CNTB $0.60
- Resistance Level
- CPIX $4.41
- CNTB $1.00
- Average True Range (ATR)
- CPIX 0.30
- CNTB 0.13
- MACD
- CPIX 0.06
- CNTB 0.03
- Stochastic Oscillator
- CPIX 98.00
- CNTB 46.73
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.